['hypoglycemia']
['glucagon (zp-glucagon)', 'glucagon (glucagen)']

        Inclusion Criteria:

          -  Women or men 18 to 60 years with type-1 diabetes on daily insulin treatment
             (basal-bolus injection regimen or insulin pump) for at least two years, on a total
             daily dose that has been stable for the last 3 months preceding enrollment (no more
             than 20% variation), and with a current level of glycated hemoglobin between 6.5% and
             10%

        Exclusion Criteria:

          -  Any history of hypoglycemic coma or hypoglycemic seizures.

          -  Any episode of severe hypoglycemia (requiring treatment) within one month prior to
             study start.

          -  Any history of pheochromocytoma or insulinoma
      